Companies / Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc.
Nasdaq: TSHACIK 1806310DALLAS, TX
Financials · FY2025
Ownership
325.8M shares outstanding · as of Aug 11, 2026
Ownership
| Insiders | 1.81% | 5,909,066 |
| 10%+ / strategic | 9.63% | 31,380,657 |
| Institutions | 73.60% | 239,802,919 |
| Public float | 14.96% | 48,740,903 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Nolan Sean P.CEOChief Executive Officer · Director | 0.89% | 2,908,257 |
Alam KamranCHIEF FINANCIAL OFFICER | 0.44% | 1,442,131 |
Nagendran SukumarPresident and Head of R&D · Director | 0.40% | 1,317,389 |
Donenberg Phillip B.Director | 0.07% | 241,289 |
Institutional holders 198
View all →| Holder | Value | % of shares |
|---|---|---|
| $140.91M | 6.35% | |
| $119.35M | 6.66% | |
| $105.29M | 7.23% | |
| $99.43M | 5.55% | |
| $90.19M | 5.03% | |
| $77.78M | 3.51% | |
| $75.63M | 4.22% | |
| $75.31M | 4.20% | |
| $74.41M | 4.15% | |
| $72.97M | 4.07% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q3 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $15.36M | +4.7M +1042.75% | 5,148,112 1.58% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $13.95M | +2.0M +10.99% | 20,691,927 6.35% of shares | medium |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common Stock | $-10.11M | -1.8M -100.00% | — | medium |
| Q4 2025 as of | Norges Bank 13F manager | New | Common Stock | $10.11M | +1.8M | 1,837,800 0.56% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Exit | Common Stock | $-7.30M | -1.3M -100.00% | — | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $4.30M | +632K +5.86% | 11,421,920 3.51% of shares | low |
| Q1 2026 as of | Rice Hall James & Associates, LLC 13F manager | Add | Common Stock | $3.01M | +674K +53.05% | 1,944,671 0.60% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $2.15M | +391K +7.59% | 5,539,001 1.70% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| RTW Investments, LP | Passive13G/A | — |
| BlackRock, Inc. | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Vestal Point Capital, LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TSHA | Common Stock | 877619106 |